Literature DB >> 34712842

Methods for measuring the evolutionary stability of engineered genomes to improve their longevity.

Scott L Nuismer1, Nathan C Layman1, Alec J Redwood2, Baca Chan2, James J Bull1.   

Abstract

Diverse applications rely on engineering microbes to carry and express foreign transgenes. This engineered baggage rarely benefits the microbe and is thus prone to rapid evolutionary loss when the microbe is propagated. For applications where a transgene must be maintained for extended periods of growth, slowing the rate of transgene evolution is critical and can be achieved by reducing either the rate of mutation or the strength of selection. Because the benefits realized by changing these quantities will not usually be equal, it is important to know which will yield the greatest improvement to the evolutionary half-life of the engineering. Here, we provide a method for jointly estimating the mutation rate of transgene loss and the strength of selection favoring these transgene-free, revertant individuals. The method requires data from serial transfer experiments in which the frequency of engineered genomes is monitored periodically. Simple mathematical models are developed that use these estimates to predict the half-life of the engineered transgene and provide quantitative predictions for how alterations to mutation and selection will influence longevity. The estimation method and predictive tools have been implemented as an interactive web application, MuSe.
© The Author(s) 2021. Published by Oxford University Press.

Entities:  

Keywords:  bacteria; estimation; in vitro; microbe; virus

Year:  2021        PMID: 34712842      PMCID: PMC8546616          DOI: 10.1093/synbio/ysab018

Source DB:  PubMed          Journal:  Synth Biol (Oxf)        ISSN: 2397-7000


  42 in total

Review 1.  Human cytomegalovirus intrahost evolution-a new avenue for understanding and controlling herpesvirus infections.

Authors:  Nicholas Renzette; Laura Gibson; Jeffrey D Jensen; Timothy F Kowalik
Journal:  Curr Opin Virol       Date:  2014-08-25       Impact factor: 7.090

2.  Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells.

Authors:  M Havenga; R Vogels; D Zuijdgeest; K Radosevic; S Mueller; M Sieuwerts; F Weichold; I Damen; J Kaspers; A Lemckert; M van Meerendonk; R van der Vlugt; L Holterman; D Hone; Y Skeiky; R Mintardjo; G Gillissen; D Barouch; J Sadoff; J Goudsmit
Journal:  J Gen Virol       Date:  2006-08       Impact factor: 3.891

3.  The population biology of bacterial plasmids: a hidden Markov model approach.

Authors:  José M Ponciano; Leen De Gelder; Eva M Top; Paul Joyce
Journal:  Genetics       Date:  2006-12-06       Impact factor: 4.562

4.  Stability of RNA virus attenuation approaches.

Authors:  Joan L Kenney; Sara M Volk; Jyotsna Pandya; Eryu Wang; Xiaodong Liang; Scott C Weaver
Journal:  Vaccine       Date:  2011-02-01       Impact factor: 3.641

Review 5.  The spectrum of adaptive mutations in experimental evolution.

Authors:  Gregory I Lang; Michael M Desai
Journal:  Genomics       Date:  2014-09-28       Impact factor: 5.736

6.  Engineering attenuated virus vaccines by controlling replication fidelity.

Authors:  Marco Vignuzzi; Emily Wendt; Raul Andino
Journal:  Nat Med       Date:  2008-02-03       Impact factor: 53.440

7.  Designing and engineering evolutionary robust genetic circuits.

Authors:  Sean C Sleight; Bryan A Bartley; Jane A Lieviant; Herbert M Sauro
Journal:  J Biol Eng       Date:  2010-11-01       Impact factor: 4.355

8.  2b or Not 2b: Experimental Evolution of Functional Exogenous Sequences in a Plant RNA Virus.

Authors:  Anouk Willemsen; Mark P Zwart; Silvia Ambrós; José L Carrasco; Santiago F Elena
Journal:  Genome Biol Evol       Date:  2017-02-01       Impact factor: 3.416

Review 9.  On the stability of sequences inserted into viral genomes.

Authors:  Anouk Willemsen; Mark P Zwart
Journal:  Virus Evol       Date:  2019-11-14

10.  Evolutionary principles and synthetic biology: avoiding a molecular tragedy of the commons with an engineered phage.

Authors:  Eric G Gladstone; Ian J Molineux; James J Bull
Journal:  J Biol Eng       Date:  2012-09-04       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.